BRAF V600 MUTATION
Clinical trials for BRAF V600 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATION trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain tumor trial adds radiation to drug cocktail for advanced melanoma
Disease control OngoingThis study tests whether adding targeted radiation (stereotactic radiosurgery) to a three-drug combination (binimetinib, encorafenib, pembrolizumab) helps control melanoma that has spread to the brain. It includes 10 adults with a specific gene mutation (BRAF V600). The main goal…
Matched conditions: BRAF V600 MUTATION
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
Scientists dig into genetic secrets of Drug-Resistant lung cancer
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at why certain lung cancers stop responding to targeted therapy (tyrosine kinase inhibitors). Researchers will analyze tumor tissue from 40 patients to find hidden genetic changes that cause drug resistance. The goal is to uncover new ways to treat these resistan…
Matched conditions: BRAF V600 MUTATION
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC